BD has written to users of its Alaris pump modules about a risk associated with two complaints of serious injury. The Food ...
Fresenius Kabi has launched its denosumab biosimilars Conexxence® and Bomyntra® across Europe following European Commission approval in July 2025 for all indications of their reference medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback